Dr. Daniel Rasor, M.D

NPI: 1043211329
Total Payments
$15,291
2024 Payments
$1,990
Companies
52
Transactions
730
Medicare Patients
1,078
Medicare Billing
$140,326

Payment Breakdown by Category

Food & Beverage$15,252 (99.7%)
Education$38.53 (0.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $15,252 723 99.7%
Education $38.53 7 0.3%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $2,224 112 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,815 69 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,226 44 $0 (2024)
Amgen Inc. $1,139 47 $0 (2024)
Lilly USA, LLC $1,135 71 $0 (2024)
ABBVIE INC. $1,070 58 $0 (2024)
GlaxoSmithKline, LLC. $950.36 51 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $675.61 26 $0 (2024)
PFIZER INC. $652.95 40 $0 (2024)
Janssen Pharmaceuticals, Inc $505.96 26 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,990 81 AstraZeneca Pharmaceuticals LP ($325.69)
2023 $2,009 98 AstraZeneca Pharmaceuticals LP ($461.11)
2022 $2,507 109 Boehringer Ingelheim Pharmaceuticals, Inc. ($346.20)
2021 $2,946 152 AbbVie Inc. ($366.53)
2020 $2,333 131 Novo Nordisk Inc ($389.71)
2019 $853.79 44 Novo Nordisk Inc ($232.88)
2018 $936.45 44 Novo Nordisk Inc ($438.75)
2017 $1,716 71 Novo Nordisk Inc ($390.27)

All Payment Transactions

730 individual payment records from CMS Open Payments — Page 1 of 30

Date Company Product Nature Form Amount Type
12/19/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $14.52 General
Category: Diabetes
12/12/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $15.69 General
Category: VACCINE
12/10/2024 Biogen, Inc. LEQEMBI (Drug) Food and Beverage In-kind items and services $17.17 General
Category: Neurology
12/04/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.74 General
Category: Respiratory
11/20/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $16.17 General
Category: Respiratory
11/14/2024 Biogen, Inc. LEQEMBI (Drug) Food and Beverage In-kind items and services $21.57 General
Category: Neurology
11/12/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $21.65 General
Category: Oncology
11/08/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $103.86 General
Category: Cardio-renal
11/07/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $19.89 General
Category: PAIN
11/05/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $14.64 General
Category: Cardio-renal
11/01/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $14.09 General
10/31/2024 Abbott Laboratories PROCLAIM (Device) Food and Beverage In-kind items and services $22.94 General
Category: Neuromodulation
10/15/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.80 General
Category: Respiratory
10/15/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $13.76 General
Category: RESPIRATORY
10/10/2024 Biogen, Inc. LEQEMBI (Drug) Food and Beverage In-kind items and services $18.52 General
Category: Neurology
10/03/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $19.25 General
Category: Diabetes
10/02/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $21.28 General
Category: RESPIRATORY
09/24/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $21.56 General
Category: VACCINES
09/19/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $14.66 General
Category: PAIN
09/10/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $13.81 General
Category: Respiratory
09/05/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $24.31 General
Category: VACCINE
09/04/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $27.74 General
Category: Oncology
09/03/2024 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $14.27 General
Category: NEUROSCIENCE
08/26/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $17.22 General
Category: Hematology
08/22/2024 SHIELD THERAPEUTICS INC ACCRUFER (Drug) Food and Beverage In-kind items and services $64.32 General
Category: Hematology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 205 418 $113,096 $35,100
2022 7 287 463 $108,160 $39,831
2021 7 328 520 $62,637 $41,547
2020 7 258 390 $47,157 $23,848
Total Patients
1,078
Total Services
1,791
Medicare Billing
$140,326
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 111 307 $89,644 $26,331 29.4%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 38 38 $11,324 $4,797 42.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 42 58 $11,948 $3,929 32.9%
96127 Assessment of emotional or behavioral problems Office 2023 14 15 $180.00 $42.13 23.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 112 266 $68,624 $21,691 31.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 53 53 $14,730 $7,013 47.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 57 79 $14,404 $4,829 33.5%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2022 15 15 $6,750 $4,171 61.8%
90662 Influenza vaccine split virus, preservative free Office 2022 16 16 $1,952 $1,097 56.2%
G0008 Administration of influenza virus vaccine Office 2022 19 19 $950.00 $575.70 60.6%
G0009 Administration of pneumococcal vaccine Office 2022 15 15 $750.00 $454.50 60.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 114 276 $37,492 $24,407 65.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 50 50 $8,170 $6,740 82.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 87 116 $11,104 $6,715 60.5%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 20 20 $3,000 $1,312 43.7%
90662 Vaccine for influenza for injection into muscle, split virus, preservation free Office 2021 19 19 $1,425 $1,240 87.0%
0013A Fee covid-19 vac 2 booster Office 2021 19 20 $800.00 $800.00 100.0%
G0008 Administration of influenza virus vaccine Office 2021 19 19 $646.00 $333.83 51.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 80 174 $27,136 $12,176 44.9%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 66 96 $9,876 $4,773 48.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 37 37 $4,765 $4,364 91.6%
90732 Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older Office 2020 17 17 $2,550 $2,015 79.0%
G0009 Administration of pneumococcal vaccine Office 2020 16 17 $765.00 $289.17 37.8%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2020 13 13 $570.00 $125.26 22.0%
36415 Insertion of needle into vein for collection of blood sample Office 2020 29 36 $1,495 $106.68 7.1%

About Dr. Daniel Rasor, M.D

Dr. Daniel Rasor, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043211329.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Rasor, M.D has received a total of $15,291 in payments from pharmaceutical and medical device companies, with $1,990 received in 2024. These payments were reported across 730 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($15,252).

As a Medicare-enrolled provider, Rasor has provided services to 1,078 Medicare beneficiaries, totaling 1,791 services with total Medicare billing of $140,326. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Austin, TX
  • Active Since 08/09/2005
  • Last Updated 04/28/2025
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1043211329

Products in Payments

  • JARDIANCE (Drug) $1,429
  • Ozempic (Drug) $1,176
  • FARXIGA (Drug) $763.34
  • UBRELVY (Drug) $733.63
  • TRELEGY ELLIPTA (Drug) $683.52
  • Kerendia (Drug) $675.61
  • BREZTRI (Drug) $546.44
  • Repatha (Biological) $466.64
  • XARELTO (Drug) $416.11
  • Vascepa (Drug) $344.89
  • VRAYLAR (Drug) $317.84
  • Victoza (Drug) $315.81
  • EMGALITY (Drug) $301.76
  • Otezla (Drug) $292.97
  • Aimovig (Biological) $217.57
  • Saxenda (Drug) $215.53
  • TRULICITY (Drug) $210.77
  • Dayvigo (Drug) $190.46
  • AIRSUPRA (Drug) $186.89
  • MOUNJARO (Drug) $181.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Austin